Advertisement
|
|
news roundup
Adaptive Clinical Systems, a provider of cloud-hosted services, has announced a partnership with Medidata, and eClinical software as a service (SaaS) company.
| Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand
 Learn More |
Catalent Pharma Solutions, a global provider of delivery technologies and development solutions for drugs, biologics, and consumer health products, announced that work to expand its packaging capabilities at its clinical facility in Shanghai, China has reached the commissioning stage and is scheduled to be completed by the end of 2018.
| Advertisement
The Potential for Disease-Modifying Therapies in Parkinson's Disease
On Demand
 Learn More |
An international biopharmaceutical company has signed a multiyear agreement with OmniComm Systems, Inc. in which the company will use OmniComm's TrialMaster EDC technology to develop clinical studies at multiple research sites to test a cancer treatment.
Clinerion has added a live data heatmap to its homepage linked directly to Clinerion's Patient Network Explorer platform and shows live data from Clinerion's international network of partner hospitals. Real-time statistics including the number of countries, sites, and patients from Clinerion's international network of partner hospitals are also now displayed.
|
|
|
| Advertisement
Cellular Biomarkers: Predicting Clinical Trial Outcomes Through the Understanding of T-cell Responses in the Human Challenge Model
On Demand
 Learn More |
| Advertisement
Neuropathic Pain Studies: Patient Selection, Study Design, and Clinical Trial Challenges
On Demand
 Learn More |
Subscribe
 |
Stay connected with Applied Clinical Trials and sign up for your print or digital issues, as well as our enewsletters.
Subscription offers » |
|
|
|
Articles
The rapid rise of targeted drugs and biologics in oncology has spurred sponsors and the FDA to innovate, leading to the creation of a variation to the typical trial design that can include multiple expansion cohorts.
There are several important factors, which should be considered prior to resorting to international patient recruitment.
|
|
Blog Posts
According to the IQVIA Institute for Human Data Science, the pharmaceutical industry loses roughly $35 billion annually as a result of temperature excursions, making transport one of the weakest links in many manufacturers' supply chains.
The decision of the leaders of the European Union over the weekend to endorse the Withdrawal Agreement for the UK's departure was historic in that it was the first time ever that the European Council had to face the imminent reality of a member state dropping out.
|
|
|
|
Read the digital edition of Applied Clinical Trials
Click here to sign up or renew your subscription |
|
|
|
|
|
